Joshua Ruch, 10% Owner at INOTEK PHARMACEUTICALS CORP (ITEK), bought 2,564,456 shares at $6.00 ($5.7M) on 2015-02-23, disclosed to the SEC on 2015-02-25.
Open-market purchase of $5.7M ITEK by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,606,230 | $0 | 0.0% |
| 2 | $6.00 | 958,226 | $5.7M | 100.0% |
| Total | $2.24 avg | 2,564,456 | $5.7M | 100% |